On June 26, 2024, the Indonesian Food and Drug Administration (FDA) issued Circular No. 10 of 2024, which establishes regulations on the labeling of healthcare products and other products, to be implemented as of the date of issuance. Main contents:

(1) Relevant definitions;

(2) General requirements for labeling. Directly printed or adhered to the package, not easily removed, and not damaged by water, friction, or exposure to sunlight;

(3) Mandatory Requirements. The following must be written and printed in Indonesian: product name and dosage form; company name and address; net weight; active ingredient name; functional claims; consumption regulations; marketing license number; shelf life; warnings, etc.; labels of imported irradiated health products must mark information such as license number of the irradiation facility that has been authorized by the country of origin; imported health products containing organic ingredients have an organic content of more than 95%;

(4) Prohibited information. Declaring that certain ingredients are not contained; images that are offensive to religion and other persons, as well as acts prohibited by laws and regulations, and so on;

(5) Penalty provisions;

(6) Transitional provisions.

A transitional period of 24 months from the date of this announcement.

Learn more: